Sign in

CIK 0001628171

  • Large accelerated filer

Revolution Medicines, Inc.

Sign in to watch
Ticker
RVMD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472029180
Phone
+1 650-481-6801
Business address
700 SAGINAW DR, REDWOOD CITY, CA, 94063

Securities

  • RVMD Common Stock Nasdaq
  • RVMDW Warrant Nasdaq
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$85,328,124
in 21 filings, $85.3M under 10b5-1 plans

Net −$85,328,124. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-10-01 GOLDSMITH MARK A See Remarks Option exercise 10b5-1 +10,000 $4.09 $41K 310,170
2024-10-01 GOLDSMITH MARK A See Remarks Sale 10b5-1 −7,978 $44.80 $357K 302,192
2024-10-01 GOLDSMITH MARK A See Remarks Sale 10b5-1 −2,022 $45.46 $92K 300,170
2024-10-01 GOLDSMITH MARK A See Remarks Option exercise · Stock Option (Right to Buy) 10b5-1 −10,000 271,229
2024-09-16 Anders Jack Chief Financial Officer Sale 10b5-1 −2,244 $44.19 $99K 98,932
2024-09-16 GOLDSMITH MARK A See Remarks Sale 10b5-1 −11,715 $44.19 $518K 300,170
2024-09-16 Horn Margaret A Chief Operating Officer Sale 10b5-1 −4,331 $44.19 $191K 132,320
2024-09-16 Kelsey Stephen Michael See Remarks Sale 10b5-1 −4,665 $44.19 $206K 264,408
2024-09-16 Cislini Jeff General Counsel Sale 10b5-1 −1,454 $44.19 $64K 45,634
2024-09-13 Kelsey Stephen Michael See Remarks Option exercise 10b5-1 +16,667 $4.09 $68K 285,740
2024-09-13 Kelsey Stephen Michael See Remarks Sale 10b5-1 −5,966 $42.75 $255K 279,774
2024-09-13 Kelsey Stephen Michael See Remarks Sale 10b5-1 −10,701 $43.65 $467K 269,073
2024-09-13 Kelsey Stephen Michael See Remarks Option exercise · Stock Option (Right to Buy) 10b5-1 −16,667 39,998
2024-08-21 Weber Barbara Director Returned to the company −1,808 $44.83 $81K 18,265
2024-08-13 Kelsey Stephen Michael See Remarks Option exercise 10b5-1 +16,667 $4.09 $68K 285,740
2024-08-13 Kelsey Stephen Michael See Remarks Sale 10b5-1 −16,667 $42.98 $716K 269,073
2024-08-13 Kelsey Stephen Michael See Remarks Option exercise · Stock Option (Right to Buy) 10b5-1 −16,667 56,665
2024-08-05 Clyburn Frank Director Grant or award · Stock Option (Right to Buy) +26,540 26,540
2024-08-05 Clyburn Frank Director Grant or award +6,932 6,932
2024-08-05 Clyburn Frank Director Grant or award · Stock Option (Right to Buy) +27,744 27,744

Page 22 of 29 · 569 trades